278 related articles for article (PubMed ID: 33782779)
1. Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations.
Wang Z; Zhou X; Zhao N; Xie C; Zhu D; Guan Y
Neurol Sci; 2021 Jun; 42(6):2223-2233. PubMed ID: 33782779
[TBL] [Abstract][Full Text] [Related]
2. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
3. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
Martinez-Martinez L; Lleixà MC; Boera-Carnicero G; Cortese A; Devaux J; Siles A; Rajabally Y; Martinez-Piñeiro A; Carvajal A; Pardo J; Delmont E; Attarian S; Diaz-Manera J; Callegari I; Marchioni E; Franciotta D; Benedetti L; Lauria G; de la Calle Martin O; Juárez C; Illa I; Querol L
J Neuroinflammation; 2017 Nov; 14(1):224. PubMed ID: 29145880
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy.
Dong M; Tai H; Yang S; Gao X; Pan H; Zhang Z
Clin Neurol Neurosurg; 2022 Dec; 223():107521. PubMed ID: 36401951
[TBL] [Abstract][Full Text] [Related]
6. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI
Front Neurol; 2021; 12():665136. PubMed ID: 34177770
[TBL] [Abstract][Full Text] [Related]
7. Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy.
Ogata H; Isobe N; Zhang X; Yamasaki R; Fujii T; Machida A; Morimoto N; Kaida K; Masuda T; Ando Y; Kuwahara M; Kusunoki S; Nakamura Y; Matsushita T; Kira JI
J Neuroimmunol; 2020 Feb; 339():577139. PubMed ID: 31864140
[TBL] [Abstract][Full Text] [Related]
8. Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.
Liberatore G; De Lorenzo A; Giannotta C; Manganelli F; Filosto M; Cosentino G; Cocito D; Briani C; Cortese A; Fazio R; Lauria G; Clerici AM; Rosso T; Marfia GA; Antonini G; Cavaletti G; Carpo M; Doneddu PE; Spina E; Cotti Piccinelli S; Peci E; Querol L; Nobile-Orazio E
Neurol Sci; 2022 Jun; 43(6):3939-3947. PubMed ID: 35048233
[TBL] [Abstract][Full Text] [Related]
9. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
[TBL] [Abstract][Full Text] [Related]
10. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
Hu W; Xin Y; He Z; Zhao Y
Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
Pascual-Goñi E; Martín-Aguilar L; Querol L
Curr Opin Neurol; 2019 Oct; 32(5):651-657. PubMed ID: 31306213
[TBL] [Abstract][Full Text] [Related]
12. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
[TBL] [Abstract][Full Text] [Related]
14. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
[TBL] [Abstract][Full Text] [Related]
15. Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy.
Wang L; Pan J; Meng H; Yang Z; Zeng L; Liu J
Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421911
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies.
Zhang J; Hou X; Wei L; Liu J; Li S; Guo Y; Liu H; Jiang Y
Front Immunol; 2024; 15():1345953. PubMed ID: 38726012
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera.
Delmont E; Brodovitch A; Kouton L; Allou T; Beltran S; Brisset M; Camdessanché JP; Cauquil C; Cirion J; Dubard T; Echaniz-Laguna A; Grapperon AM; Jauffret J; Juntas-Morales R; Kremer LD; Kuntzer T; Labeyrie C; Lanfranco L; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Nicolas G; Noury JB; Perie M; Rajabally YA; Remiche G; Rouaud V; Tard C; Salort-Campana E; Verschueren A; Viala K; Wang A; Attarian S; Boucraut J
J Neurol; 2020 Dec; 267(12):3664-3672. PubMed ID: 32676765
[TBL] [Abstract][Full Text] [Related]
18. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy.
Zhang L; Zhang Y; Li R; Zhu J; Lin A; Yan Y; Zhang Z; Wang N; Xu G; Fu Y
J Neurol; 2024 May; ():. PubMed ID: 38771386
[TBL] [Abstract][Full Text] [Related]
19. Anti-neurofascin autoantibody and demyelination.
Kira JI; Yamasaki R; Ogata H
Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile of autoimmune nodopathy with anti-neurofascin 186 antibody.
Liu B; Zhou L; Sun C; Wang L; Zheng Y; Hu B; Qiao K; Zhao C; Lu J; Lin J
Ann Clin Transl Neurol; 2023 Jun; 10(6):944-952. PubMed ID: 37060203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
